Project Number 2P50AG016574-11 Agency/Funding Organization NIA Funding Year 2009 View Full Project Details for IDENTIFICATION OF AD RISK VARIANTS BY GENOME WIDE ASSOCIATION OF GENE EXPRESSIO Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 17. Genetics a. Genome-Wide Association Studies and imputation analysis Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator ERTEKIN-TANER, NILUFER Principal Investigator First Name GUOJUN Principal Investigator Last Name BU Awardee Organization MAYO CLINIC ROCHESTER Awardee State Minnesota Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-09-001: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $191,251 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PHELPS, CREIGHTON H. Related Resources Repository National Alzheimer's Coordinating Center (NACC) National Alzheimer's Coordinating Center (NACC) [AlzPED] Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. [AlzPED] Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice Clinical Trial Tau PET Imaging in African Americans ''Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies'' Pagination Previous page ‹‹ Page 2
